Indecainide
Decabid (indecainide) is a small molecule pharmaceutical. Indecainide was first approved as Decabid on 1989-12-29.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Indecainide hydrochloride
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| DECABID | Eli Lilly | N-019693 DISCN | 1989-12-29 | 3 products |
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
87 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Stroke | D020521 | EFO_0000712 | I63.9 | — | — | 1 | 3 | 1 | 5 |
| Torticollis | D014103 | HP_0000473 | F45.8 | — | — | 1 | 2 | 1 | 4 |
| Muscle spasticity | D009128 | HP_0001257 | — | — | — | 1 | 1 | 2 | |
| Sleep bruxism | D020186 | G47.63 | — | — | — | 1 | — | 1 | |
| Fissure in ano | D005401 | HP_0012390 | K60.2 | — | — | — | 1 | — | 1 |
| Stroke rehabilitation | D000071939 | — | — | — | 1 | — | 1 | ||
| Plantar fasciitis | D036981 | EFO_1001909 | M72.2 | — | — | — | 1 | — | 1 |
| Skin aging | D015595 | EFO_0005422 | — | — | — | 1 | — | 1 | |
| Thoracic outlet syndrome | D013901 | EFO_0007507 | G54.0 | — | — | — | 1 | — | 1 |
| Whiplash injuries | D014911 | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cerebral palsy | D002547 | G80 | — | 2 | 4 | — | 1 | 7 | |
| Overactive urinary bladder | D053201 | EFO_1000781 | N32.81 | — | 1 | 1 | — | 1 | 3 |
| Traumatic brain injuries | D000070642 | S06 | — | — | 3 | — | — | 3 | |
| Sialorrhea | D012798 | HP_0002307 | K11.7 | — | 1 | 3 | — | — | 3 |
| Blepharospasm | D001764 | G24.5 | — | 1 | 1 | — | 1 | 3 | |
| Parkinson disease | D010300 | EFO_0002508 | G20 | — | — | 2 | — | — | 2 |
| Electromyography | D004576 | — | — | 1 | — | — | 1 | ||
| Beckwith-wiedemann syndrome | D001506 | Q87.3 | — | — | 1 | — | — | 1 | |
| Pelvic pain | D017699 | — | — | 1 | — | — | 1 | ||
| Pelvic floor disorders | D059952 | — | — | 1 | — | — | 1 |
Show 4 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Essential tremor | D020329 | EFO_0003108 | G25.0 | — | 2 | — | — | — | 2 |
| Tremor | D014202 | R25.1 | — | 2 | — | — | — | 2 | |
| Pain | D010146 | EFO_0003843 | R52 | — | 2 | — | — | — | 2 |
| Migraine disorders | D008881 | EFO_0003821 | G43 | — | 1 | — | — | — | 1 |
| Chronic disease | D002908 | — | 1 | — | — | — | 1 | ||
| Interstitial cystitis | D018856 | EFO_1000869 | N30.1 | — | 1 | — | — | — | 1 |
| Paraplegia | D010264 | HP_0001258 | G82.2 | — | 1 | — | — | — | 1 |
| Trigeminal neuralgia | D014277 | EFO_1001219 | G50.0 | — | 1 | — | — | — | 1 |
| Restless legs syndrome | D012148 | EFO_0004270 | G25.81 | — | 1 | — | — | — | 1 |
| Sleep apnea syndromes | D012891 | EFO_0003877 | G47.3 | — | 1 | — | — | — | 1 |
Show 5 more
Indications Phases 1
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | INDECAINIDE |
| INN | indecainide |
| Description | Indecainide is a member of fluorenes. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | CC(C)NCCCC1(C(N)=O)c2ccccc2-c2ccccc21 |
Identifiers
| PDB | — |
| CAS-ID | 74517-78-5 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1201242 |
| ChEBI ID | — |
| PubChem CID | 52195 |
| DrugBank | DB00192 |
| UNII ID | 3AZF20DM1T (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 11 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
2,322 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more